Cleared Traditional

K914253 - PROCLINIC ONE STEP PREGNANCY TEST

K914253 is an FDA 510(k) clearance for PROCLINIC ONE STEP PREGNANCY TEST, manufactured by Vanguard Biomedical Corp.. The device is a Class 2 Chemistry device with product code JHI cleared through the Traditional 510(k) pathway after a 18-day FDA review.

K914253 · Vanguard Biomedical Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1991
Decision
18d
Days
Class 2
Risk

K914253 is an FDA 510(k) clearance for the PROCLINIC ONE STEP PREGNANCY TEST. Classified as Visual, Pregnancy Hcg, Prescription Use (product code JHI), Class II - Special Controls.

Submitted by Vanguard Biomedical Corp. (San Diego, US). The FDA issued a Cleared decision on October 11, 1991 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vanguard Biomedical Corp. devices

FDA 510(k) Submission Details - K914253

510(k) Number K914253 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 1991
Decision Date October 11, 1991
Days to Decision 18 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 88d · This submission: 18d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHI Device Classification - Class 2, Special Controls

Product Code JHI Visual, Pregnancy Hcg, Prescription Use
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHI Visual, Pregnancy Hcg, Prescription Use

All 283
Devices cleared under the same product code (JHI) and FDA review panel - the closest regulatory comparables to K914253.
KODAK SURECELL(TM) HCG URINE TEST KIT/MODIFICATION
K915701 · Eastman Kodak Company · Jan 1992
MEDIX BIOTECH TOTAL HCG ENZY IMMUN TEST KT DIF4011
K914696 · Medix Biotech, Inc. · Nov 1991
CLEARVIEW HCG SERUM/URINE PROFESS PREG TEST, MODIF
K914240 · Unipath , Ltd. · Oct 1991
TARGET(TM)-HOG
K914303 · V-Tech, Inc. · Oct 1991
DIRECTIGEN 1-2-3(TM) HCG TEST
K913122 · Quidel Corp. · Aug 1991
IMMUNOCARD HCG ONE STEP (I-S) TEST KIT
K911826 · Disease Detection International, Inc. · Jul 1991